| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystonia | 74 | 2022 | 363 | 7.330 |
Why?
|
| Dystonic Disorders | 48 | 2022 | 329 | 7.080 |
Why?
|
| Dystonia Musculorum Deformans | 45 | 2020 | 158 | 4.020 |
Why?
|
| Molecular Chaperones | 43 | 2021 | 742 | 3.380 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 22 | 2022 | 494 | 2.610 |
Why?
|
| Jews | 42 | 2021 | 385 | 2.160 |
Why?
|
| Parkinsonian Disorders | 19 | 2023 | 275 | 2.110 |
Why?
|
| Genetic Diseases, X-Linked | 11 | 2022 | 372 | 2.020 |
Why?
|
| Apoptosis Regulatory Proteins | 17 | 2021 | 1157 | 1.940 |
Why?
|
| Parkinson Disease | 47 | 2022 | 2775 | 1.730 |
Why?
|
| Myoclonus | 21 | 2012 | 104 | 1.580 |
Why?
|
| DNA Repeat Expansion | 3 | 2019 | 66 | 1.470 |
Why?
|
| Mutation | 99 | 2023 | 29786 | 1.460 |
Why?
|
| Sarcoglycans | 16 | 2013 | 55 | 1.230 |
Why?
|
| TATA-Binding Protein Associated Factors | 5 | 2020 | 104 | 1.140 |
Why?
|
| Chromosomes, Human, Pair 9 | 29 | 1999 | 535 | 1.080 |
Why?
|
| Transcription Factor TFIID | 5 | 2020 | 151 | 1.020 |
Why?
|
| Hemiplegia | 7 | 2019 | 135 | 1.020 |
Why?
|
| DNA-Binding Proteins | 20 | 2021 | 9648 | 0.980 |
Why?
|
| Carrier Proteins | 30 | 2016 | 5021 | 0.960 |
Why?
|
| Histone Acetyltransferases | 5 | 2020 | 336 | 0.920 |
Why?
|
| Age of Onset | 47 | 2022 | 3271 | 0.880 |
Why?
|
| Nuclear Proteins | 15 | 2018 | 5853 | 0.860 |
Why?
|
| GTP-Binding Protein alpha Subunits | 5 | 2018 | 100 | 0.850 |
Why?
|
| Genetic Linkage | 50 | 2013 | 2421 | 0.850 |
Why?
|
| Glucosylceramidase | 8 | 2023 | 124 | 0.840 |
Why?
|
| Pedigree | 69 | 2020 | 4644 | 0.780 |
Why?
|
| Dysphonia | 6 | 2021 | 144 | 0.760 |
Why?
|
| Genetic Predisposition to Disease | 34 | 2021 | 17446 | 0.740 |
Why?
|
| DNA Mutational Analysis | 37 | 2017 | 4186 | 0.690 |
Why?
|
| Short Interspersed Nucleotide Elements | 2 | 2018 | 40 | 0.670 |
Why?
|
| Penetrance | 11 | 2021 | 381 | 0.660 |
Why?
|
| Retroelements | 3 | 2022 | 164 | 0.660 |
Why?
|
| Heterozygote | 30 | 2023 | 2804 | 0.640 |
Why?
|
| Family Health | 10 | 2015 | 1282 | 0.630 |
Why?
|
| Serine | 7 | 2018 | 826 | 0.600 |
Why?
|
| Phenotype | 44 | 2021 | 16365 | 0.580 |
Why?
|
| GTP Cyclohydrolase | 6 | 2017 | 46 | 0.540 |
Why?
|
| Ligases | 9 | 2003 | 333 | 0.540 |
Why?
|
| Glycine | 6 | 2018 | 671 | 0.510 |
Why?
|
| Mutation, Missense | 8 | 2010 | 2564 | 0.510 |
Why?
|
| Chromosome Mapping | 34 | 2014 | 4740 | 0.500 |
Why?
|
| Polymorphism, Genetic | 31 | 2008 | 4328 | 0.440 |
Why?
|
| Polymorphism, Restriction Fragment Length | 20 | 2004 | 768 | 0.420 |
Why?
|
| Point Mutation | 8 | 2008 | 1623 | 0.400 |
Why?
|
| Tubulin | 5 | 2020 | 695 | 0.400 |
Why?
|
| Genotype | 33 | 2021 | 12951 | 0.400 |
Why?
|
| Movement Disorders | 6 | 2019 | 445 | 0.390 |
Why?
|
| Haplotypes | 18 | 2018 | 2779 | 0.380 |
Why?
|
| Founder Effect | 6 | 2021 | 189 | 0.370 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 10 | 2019 | 798 | 0.370 |
Why?
|
| Genetic Variation | 9 | 2020 | 6544 | 0.360 |
Why?
|
| Humans | 260 | 2023 | 744343 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 19 | 5 | 2013 | 367 | 0.360 |
Why?
|
| Male | 169 | 2023 | 350118 | 0.350 |
Why?
|
| Genes, Dominant | 16 | 2004 | 880 | 0.350 |
Why?
|
| Cytoskeletal Proteins | 6 | 2004 | 1364 | 0.330 |
Why?
|
| Multiple System Atrophy | 2 | 2007 | 121 | 0.320 |
Why?
|
| Genetic Markers | 29 | 2009 | 2634 | 0.310 |
Why?
|
| Female | 163 | 2023 | 380194 | 0.300 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2021 | 15519 | 0.300 |
Why?
|
| Sequence Deletion | 11 | 2010 | 1526 | 0.300 |
Why?
|
| Gaucher Disease | 2 | 2023 | 112 | 0.300 |
Why?
|
| Ubiquitin-Protein Ligases | 10 | 2004 | 1861 | 0.300 |
Why?
|
| Gene Deletion | 10 | 2009 | 2751 | 0.300 |
Why?
|
| Deep Brain Stimulation | 4 | 2019 | 748 | 0.300 |
Why?
|
| Gene Frequency | 17 | 2018 | 3588 | 0.290 |
Why?
|
| Substantia Nigra | 7 | 2011 | 353 | 0.290 |
Why?
|
| DNA, Intergenic | 1 | 2007 | 107 | 0.290 |
Why?
|
| Genetic Testing | 15 | 2016 | 3444 | 0.280 |
Why?
|
| Brain | 18 | 2021 | 26385 | 0.280 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1941 | 0.280 |
Why?
|
| Olfaction Disorders | 3 | 2022 | 222 | 0.280 |
Why?
|
| Laryngeal Diseases | 2 | 2020 | 241 | 0.270 |
Why?
|
| Adult | 112 | 2022 | 214055 | 0.270 |
Why?
|
| Exons | 14 | 2021 | 2437 | 0.270 |
Why?
|
| Middle Aged | 98 | 2021 | 213383 | 0.270 |
Why?
|
| Cerebellum | 6 | 2020 | 1488 | 0.270 |
Why?
|
| Molecular Sequence Data | 25 | 2012 | 18111 | 0.270 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1903 | 0.270 |
Why?
|
| Tremor | 3 | 2008 | 175 | 0.260 |
Why?
|
| Gene Order | 2 | 2017 | 176 | 0.260 |
Why?
|
| Torticollis | 4 | 2019 | 66 | 0.260 |
Why?
|
| Genetic Loci | 6 | 2021 | 2575 | 0.250 |
Why?
|
| Aged | 75 | 2021 | 163280 | 0.240 |
Why?
|
| Introns | 8 | 2020 | 991 | 0.240 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 2007 | 1444 | 0.230 |
Why?
|
| Voice Disorders | 2 | 2020 | 276 | 0.230 |
Why?
|
| Membrane Glycoproteins | 6 | 2004 | 3768 | 0.230 |
Why?
|
| Monoamine Oxidase | 5 | 1992 | 178 | 0.230 |
Why?
|
| Alleles | 24 | 2021 | 6933 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 18 | 4 | 2003 | 245 | 0.220 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2004 | 211 | 0.210 |
Why?
|
| Cholesterol Ester Transfer Proteins | 2 | 2016 | 110 | 0.210 |
Why?
|
| Gene Expression | 11 | 2019 | 7799 | 0.210 |
Why?
|
| Genetic Association Studies | 5 | 2017 | 2703 | 0.200 |
Why?
|
| Tourette Syndrome | 1 | 2004 | 379 | 0.200 |
Why?
|
| Unfolded Protein Response | 2 | 2020 | 233 | 0.200 |
Why?
|
| Adolescent | 59 | 2021 | 85781 | 0.200 |
Why?
|
| Linkage Disequilibrium | 6 | 2012 | 1997 | 0.200 |
Why?
|
| Endophenotypes | 2 | 2020 | 250 | 0.190 |
Why?
|
| Base Sequence | 16 | 2018 | 12797 | 0.180 |
Why?
|
| Histones | 2 | 2020 | 2599 | 0.180 |
Why?
|
| Family | 9 | 2020 | 3147 | 0.180 |
Why?
|
| Dopamine | 4 | 2005 | 1591 | 0.180 |
Why?
|
| Child | 47 | 2021 | 77709 | 0.170 |
Why?
|
| Genes | 7 | 1990 | 1893 | 0.160 |
Why?
|
| Receptors, Dopamine | 1 | 1999 | 295 | 0.160 |
Why?
|
| Nystagmus, Pathologic | 1 | 1998 | 96 | 0.160 |
Why?
|
| Chromosome Deletion | 7 | 2017 | 1401 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 13 | 2005 | 6171 | 0.150 |
Why?
|
| Lod Score | 10 | 2004 | 614 | 0.150 |
Why?
|
| Amino Acid Sequence | 10 | 2012 | 13815 | 0.150 |
Why?
|
| Myelin Sheath | 1 | 2021 | 652 | 0.150 |
Why?
|
| Sequence Alignment | 4 | 2012 | 2256 | 0.150 |
Why?
|
| Dihydroxyphenylalanine | 4 | 2010 | 76 | 0.150 |
Why?
|
| beta-Glucosidase | 1 | 2016 | 12 | 0.150 |
Why?
|
| Protein Folding | 1 | 2020 | 843 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 5 | 2017 | 5867 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2017 | 162 | 0.150 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 5 | 1991 | 170 | 0.140 |
Why?
|
| Crohn Disease | 3 | 2018 | 2303 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2007 | 460 | 0.140 |
Why?
|
| Microsatellite Repeats | 4 | 2007 | 802 | 0.140 |
Why?
|
| Huntington Disease | 2 | 2022 | 1124 | 0.140 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2017 | 95 | 0.140 |
Why?
|
| Ataxia | 2 | 2016 | 304 | 0.140 |
Why?
|
| Multigene Family | 1 | 1999 | 1102 | 0.140 |
Why?
|
| Cadherins | 1 | 2021 | 907 | 0.140 |
Why?
|
| Proteins | 4 | 2000 | 6103 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 17 | 7 | 1999 | 437 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 441 | 0.140 |
Why?
|
| Dementia | 2 | 2010 | 2518 | 0.140 |
Why?
|
| Memory Disorders | 2 | 2016 | 1184 | 0.130 |
Why?
|
| Levodopa | 3 | 2009 | 219 | 0.130 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2016 | 190 | 0.130 |
Why?
|
| Brain Mapping | 5 | 2018 | 6669 | 0.130 |
Why?
|
| Antiparkinson Agents | 3 | 2010 | 184 | 0.130 |
Why?
|
| Globus Pallidus | 2 | 2018 | 253 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 4 | 2002 | 475 | 0.130 |
Why?
|
| Heat-Shock Proteins | 2 | 2006 | 822 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 12072 | 0.130 |
Why?
|
| Mood Disorders | 2 | 2012 | 1106 | 0.130 |
Why?
|
| Eye Abnormalities | 1 | 2017 | 246 | 0.130 |
Why?
|
| Brazil | 2 | 2010 | 1270 | 0.120 |
Why?
|
| Neurons | 7 | 2018 | 9338 | 0.120 |
Why?
|
| X Chromosome | 5 | 1994 | 814 | 0.120 |
Why?
|
| Prefrontal Cortex | 3 | 2020 | 2147 | 0.120 |
Why?
|
| DNA | 20 | 2021 | 7301 | 0.120 |
Why?
|
| Catastrophic Illness | 1 | 2015 | 57 | 0.120 |
Why?
|
| Genealogy and Heraldry | 1 | 2014 | 28 | 0.120 |
Why?
|
| Tuberous Sclerosis | 4 | 1999 | 1029 | 0.120 |
Why?
|
| Reference Standards | 1 | 2018 | 1025 | 0.120 |
Why?
|
| Genome-Wide Association Study | 6 | 2021 | 12261 | 0.120 |
Why?
|
| Laminin | 1 | 2015 | 419 | 0.120 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 391 | 0.120 |
Why?
|
| Aging | 3 | 2010 | 8664 | 0.120 |
Why?
|
| Genetic Heterogeneity | 3 | 2007 | 733 | 0.120 |
Why?
|
| RNA, Messenger | 8 | 2018 | 13033 | 0.120 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 166 | 0.120 |
Why?
|
| Respiratory Paralysis | 1 | 2014 | 31 | 0.120 |
Why?
|
| Neuropsychological Tests | 8 | 2016 | 6993 | 0.120 |
Why?
|
| Child, Preschool | 26 | 2020 | 41006 | 0.120 |
Why?
|
| Germ-Line Mutation | 2 | 1999 | 1788 | 0.120 |
Why?
|
| Motor Skills Disorders | 1 | 2014 | 90 | 0.110 |
Why?
|
| Young Adult | 16 | 2021 | 56430 | 0.110 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2013 | 192 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2022 | 1563 | 0.110 |
Why?
|
| Genome, Human | 5 | 2018 | 4420 | 0.110 |
Why?
|
| Thalamus | 4 | 2020 | 1023 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2013 | 91 | 0.110 |
Why?
|
| Alcoholism | 3 | 2012 | 1906 | 0.110 |
Why?
|
| Genetics, Population | 3 | 2014 | 934 | 0.110 |
Why?
|
| Disease | 1 | 2018 | 680 | 0.110 |
Why?
|
| Fibroblasts | 7 | 2020 | 4161 | 0.110 |
Why?
|
| Glutamine | 1 | 2015 | 578 | 0.110 |
Why?
|
| Corpus Striatum | 5 | 2014 | 1221 | 0.110 |
Why?
|
| Serine Endopeptidases | 1 | 1998 | 1072 | 0.110 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 4 | 2003 | 335 | 0.110 |
Why?
|
| Transfection | 5 | 2015 | 5892 | 0.100 |
Why?
|
| HEK293 Cells | 5 | 2020 | 4204 | 0.100 |
Why?
|
| Neurology | 1 | 2020 | 763 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 1061 | 0.100 |
Why?
|
| Chorea | 1 | 2012 | 74 | 0.100 |
Why?
|
| Aged, 80 and over | 22 | 2020 | 57776 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 1783 | 0.100 |
Why?
|
| Research | 1 | 2020 | 1999 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2002 | 2839 | 0.100 |
Why?
|
| Ataxia Telangiectasia | 1 | 2012 | 112 | 0.100 |
Why?
|
| Cell Survival | 2 | 2020 | 5882 | 0.100 |
Why?
|
| Estrogen Receptor beta | 1 | 2011 | 175 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1222 | 0.090 |
Why?
|
| Larynx | 1 | 2015 | 494 | 0.090 |
Why?
|
| Speech | 1 | 2015 | 540 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 1992 | 265 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 1999 | 3023 | 0.090 |
Why?
|
| Cognition Disorders | 3 | 2018 | 4043 | 0.090 |
Why?
|
| Homozygote | 4 | 2016 | 1785 | 0.090 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 1194 | 0.090 |
Why?
|
| Neurophysiology | 1 | 2011 | 142 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2017 | 1357 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 1438 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 300 | 0.090 |
Why?
|
| 5' Untranslated Regions | 1 | 2011 | 249 | 0.090 |
Why?
|
| Prenatal Diagnosis | 3 | 2015 | 1236 | 0.090 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 5708 | 0.090 |
Why?
|
| Umbilical Veins | 1 | 2010 | 433 | 0.090 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2009 | 1085 | 0.090 |
Why?
|
| Siblings | 1 | 2014 | 854 | 0.090 |
Why?
|
| Oncogene Proteins | 2 | 2004 | 749 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3462 | 0.090 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 4 | 2012 | 292 | 0.090 |
Why?
|
| Cells, Cultured | 10 | 2020 | 19229 | 0.090 |
Why?
|
| Frameshift Mutation | 2 | 2003 | 399 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 4 | 2020 | 1144 | 0.080 |
Why?
|
| Syndrome | 7 | 2008 | 3251 | 0.080 |
Why?
|
| Christianity | 2 | 2007 | 47 | 0.080 |
Why?
|
| Phenylalanine | 2 | 2004 | 365 | 0.080 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 2008 | 68 | 0.080 |
Why?
|
| Brain Chemistry | 3 | 2004 | 981 | 0.080 |
Why?
|
| Nervous System Diseases | 3 | 2015 | 1622 | 0.080 |
Why?
|
| Epilepsies, Myoclonic | 2 | 2003 | 80 | 0.080 |
Why?
|
| Animals | 23 | 2022 | 168757 | 0.080 |
Why?
|
| Sleep Deprivation | 1 | 2015 | 832 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2011 | 720 | 0.080 |
Why?
|
| Spine | 1 | 2015 | 1144 | 0.080 |
Why?
|
| Status Epilepticus | 1 | 2014 | 444 | 0.080 |
Why?
|
| Mice | 16 | 2021 | 81183 | 0.080 |
Why?
|
| Motor Activity | 2 | 2017 | 2714 | 0.080 |
Why?
|
| DNA Probes | 6 | 1992 | 560 | 0.080 |
Why?
|
| Disease Progression | 8 | 2021 | 13284 | 0.080 |
Why?
|
| Case-Control Studies | 7 | 2021 | 21746 | 0.080 |
Why?
|
| Trinucleotide Repeats | 3 | 2010 | 261 | 0.080 |
Why?
|
| Karyotyping | 3 | 1999 | 1243 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1992 | 849 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 2010 | 1107 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 893 | 0.080 |
Why?
|
| Italy | 2 | 2000 | 832 | 0.070 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.070 |
Why?
|
| Epilepsy | 3 | 2015 | 3310 | 0.070 |
Why?
|
| Glomerular Mesangium | 1 | 2006 | 108 | 0.070 |
Why?
|
| Models, Molecular | 5 | 2018 | 5456 | 0.070 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2008 | 245 | 0.070 |
Why?
|
| Dopamine beta-Hydroxylase | 3 | 1991 | 75 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 1901 | 0.070 |
Why?
|
| Dysautonomia, Familial | 3 | 1993 | 95 | 0.070 |
Why?
|
| Binding Sites, Antibody | 1 | 2006 | 349 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 1791 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2018 | 3743 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1999 | 375 | 0.070 |
Why?
|
| Nerve Net | 1 | 2018 | 2174 | 0.070 |
Why?
|
| Neurofibromatosis 1 | 5 | 1989 | 569 | 0.070 |
Why?
|
| Dopamine Agents | 2 | 2005 | 189 | 0.070 |
Why?
|
| Actinin | 1 | 2006 | 160 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 3505 | 0.060 |
Why?
|
| Germany | 4 | 2004 | 862 | 0.060 |
Why?
|
| DNA Primers | 3 | 2004 | 2892 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2002 | 322 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2011 | 1534 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 1 | 2006 | 326 | 0.060 |
Why?
|
| Gene Dosage | 5 | 2016 | 1252 | 0.060 |
Why?
|
| Alanine | 1 | 2007 | 572 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2011 | 2969 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2007 | 576 | 0.060 |
Why?
|
| Neurologic Examination | 3 | 2002 | 930 | 0.060 |
Why?
|
| Protein Transport | 2 | 2020 | 1988 | 0.060 |
Why?
|
| Glycosaminoglycans | 1 | 2007 | 624 | 0.060 |
Why?
|
| Risk | 3 | 2014 | 9687 | 0.060 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15540 | 0.060 |
Why?
|
| New York City | 1 | 2006 | 710 | 0.060 |
Why?
|
| Synucleins | 2 | 2001 | 110 | 0.060 |
Why?
|
| Endopeptidase Clp | 2 | 2006 | 47 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2011 | 2740 | 0.060 |
Why?
|
| Nuclear Envelope | 1 | 2004 | 172 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2004 | 563 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2003 | 330 | 0.050 |
Why?
|
| Gait | 1 | 2008 | 793 | 0.050 |
Why?
|
| Cohort Studies | 9 | 2018 | 40561 | 0.050 |
Why?
|
| Risk Factors | 9 | 2018 | 72290 | 0.050 |
Why?
|
| Cell Line | 7 | 2017 | 15997 | 0.050 |
Why?
|
| Codon, Nonsense | 2 | 2004 | 281 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2021 | 6882 | 0.050 |
Why?
|
| Parietal Lobe | 2 | 2020 | 838 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2006 | 3129 | 0.050 |
Why?
|
| Europe | 3 | 2006 | 3339 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4751 | 0.050 |
Why?
|
| Anxiety | 1 | 2016 | 4297 | 0.050 |
Why?
|
| RNA | 2 | 2011 | 2749 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 3 | 2016 | 4462 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3200 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2022 | 1730 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2011 | 2585 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2020 | 35421 | 0.050 |
Why?
|
| Host Cell Factor C1 | 1 | 2021 | 31 | 0.050 |
Why?
|
| Extremities | 1 | 2007 | 865 | 0.050 |
Why?
|
| Gene Products, gag | 1 | 2002 | 337 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 2 | 2002 | 1144 | 0.050 |
Why?
|
| Genomic Imprinting | 3 | 2013 | 328 | 0.050 |
Why?
|
| Regression Analysis | 4 | 2013 | 6459 | 0.050 |
Why?
|
| YY1 Transcription Factor | 1 | 2021 | 60 | 0.050 |
Why?
|
| Models, Biological | 1 | 2017 | 9583 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2020 | 23403 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2017 | 11483 | 0.050 |
Why?
|
| Lewy Bodies | 1 | 2001 | 137 | 0.050 |
Why?
|
| Motor Cortex | 2 | 2020 | 986 | 0.050 |
Why?
|
| Cognition | 2 | 2017 | 6770 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2002 | 462 | 0.050 |
Why?
|
| Ornithine | 1 | 2020 | 78 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 2690 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 1993 | 354 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1677 | 0.050 |
Why?
|
| Chromosomes | 1 | 2004 | 596 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 10638 | 0.050 |
Why?
|
| Infant | 11 | 2020 | 35136 | 0.050 |
Why?
|
| Telomere-Binding Proteins | 1 | 2021 | 116 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 2 | 2015 | 245 | 0.050 |
Why?
|
| Muscle Cramp | 2 | 1998 | 35 | 0.050 |
Why?
|
| Smell | 1 | 2022 | 244 | 0.050 |
Why?
|
| Tyrosine | 1 | 2004 | 1461 | 0.050 |
Why?
|
| Intermediate Filaments | 1 | 2020 | 175 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2019 | 9849 | 0.040 |
Why?
|
| Cosmids | 2 | 1997 | 107 | 0.040 |
Why?
|
| Leukocyte Elastase | 1 | 2020 | 113 | 0.040 |
Why?
|
| Nail-Patella Syndrome | 2 | 1997 | 13 | 0.040 |
Why?
|
| Music | 2 | 2000 | 263 | 0.040 |
Why?
|
| Gliosis | 1 | 2020 | 245 | 0.040 |
Why?
|
| Proteostasis Deficiencies | 1 | 2019 | 38 | 0.040 |
Why?
|
| Executive Function | 1 | 2008 | 1364 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2020 | 393 | 0.040 |
Why?
|
| Restless Legs Syndrome | 1 | 2002 | 228 | 0.040 |
Why?
|
| Genes, Recessive | 3 | 2002 | 641 | 0.040 |
Why?
|
| Lewy Body Disease | 2 | 2017 | 229 | 0.040 |
Why?
|
| Positron-Emission Tomography | 5 | 2013 | 6234 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2016 | 6038 | 0.040 |
Why?
|
| Nucleotides | 2 | 2018 | 464 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 2 | 2006 | 839 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14557 | 0.040 |
Why?
|
| Neuronal Plasticity | 2 | 2018 | 1422 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2006 | 2050 | 0.040 |
Why?
|
| Microfilament Proteins | 3 | 2006 | 1152 | 0.040 |
Why?
|
| Cloning, Molecular | 5 | 2002 | 4320 | 0.040 |
Why?
|
| Collagenases | 1 | 1998 | 228 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1999 | 326 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2014 | 2849 | 0.040 |
Why?
|
| Protein Binding | 1 | 2010 | 9386 | 0.040 |
Why?
|
| Switzerland | 1 | 1998 | 255 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 426 | 0.040 |
Why?
|
| Age Factors | 5 | 2015 | 18370 | 0.040 |
Why?
|
| Acetylation | 1 | 2020 | 1085 | 0.040 |
Why?
|
| Alternative Splicing | 2 | 2018 | 1117 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3479 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 119 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 1999 | 449 | 0.040 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1997 | 118 | 0.040 |
Why?
|
| Russia | 1 | 1998 | 408 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1998 | 380 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1997 | 143 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1998 | 373 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2018 | 165 | 0.040 |
Why?
|
| Peroxidase | 1 | 2020 | 611 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.040 |
Why?
|
| Pennsylvania | 1 | 1998 | 613 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 21827 | 0.040 |
Why?
|
| Depression | 1 | 2016 | 7766 | 0.040 |
Why?
|
| alpha-Synuclein | 2 | 2001 | 723 | 0.040 |
Why?
|
| Disability Evaluation | 2 | 2016 | 1827 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 2 | 2013 | 655 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 3507 | 0.040 |
Why?
|
| Autopsy | 1 | 2020 | 1020 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2016 | 80 | 0.040 |
Why?
|
| Protein Stability | 1 | 2018 | 557 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2021 | 594 | 0.040 |
Why?
|
| Demography | 2 | 2014 | 1656 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1226 | 0.030 |
Why?
|
| Temperature | 1 | 2022 | 2206 | 0.030 |
Why?
|
| K562 Cells | 1 | 2018 | 634 | 0.030 |
Why?
|
| Activities of Daily Living | 2 | 2018 | 2418 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 168 | 0.030 |
Why?
|
| Chemokines | 1 | 2020 | 970 | 0.030 |
Why?
|
| Neural Pathways | 2 | 2018 | 2972 | 0.030 |
Why?
|
| Europe, Eastern | 2 | 1993 | 75 | 0.030 |
Why?
|
| Judaism | 1 | 2015 | 30 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 1998 | 7722 | 0.030 |
Why?
|
| Japan | 2 | 2002 | 1360 | 0.030 |
Why?
|
| Spasms, Infantile | 1 | 2019 | 305 | 0.030 |
Why?
|
| Species Specificity | 1 | 1999 | 2478 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2010 | 3481 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2018 | 3494 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 509 | 0.030 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 33 | 0.030 |
Why?
|
| Ouabain | 1 | 2015 | 264 | 0.030 |
Why?
|
| Nerve Tissue | 1 | 2014 | 79 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2018 | 810 | 0.030 |
Why?
|
| France | 3 | 2008 | 517 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2021 | 1149 | 0.030 |
Why?
|
| Touch Perception | 1 | 2015 | 114 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 1989 | 1081 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1997 | 560 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 4803 | 0.030 |
Why?
|
| RNA Splicing | 1 | 1999 | 907 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1994 | 299 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2014 | 128 | 0.030 |
Why?
|
| Deglutition Disorders | 2 | 2010 | 605 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 970 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1992 | 708 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2015 | 500 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9438 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 13989 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 365 | 0.030 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 1993 | 28 | 0.030 |
Why?
|
| Anisotropy | 1 | 2017 | 1265 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.030 |
Why?
|
| Locomotion | 1 | 2015 | 378 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2018 | 970 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2020 | 1670 | 0.030 |
Why?
|
| Turkey | 2 | 2004 | 237 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2013 | 2016 | 0.030 |
Why?
|
| Rest | 1 | 2018 | 901 | 0.030 |
Why?
|
| Astrocytes | 1 | 2020 | 1270 | 0.030 |
Why?
|
| Apoptosis | 2 | 2020 | 9727 | 0.030 |
Why?
|
| Canada | 3 | 2012 | 2065 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2018 | 1185 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2012 | 6600 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2002 | 417 | 0.030 |
Why?
|
| Lymphocytes | 3 | 1997 | 2617 | 0.030 |
Why?
|
| Precipitating Factors | 1 | 2012 | 52 | 0.030 |
Why?
|
| Phylogeny | 1 | 1999 | 2803 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 2726 | 0.030 |
Why?
|
| Tenascin | 1 | 1992 | 59 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2014 | 2255 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1993 | 287 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1866 | 0.030 |
Why?
|
| Crossing Over, Genetic | 1 | 1992 | 95 | 0.030 |
Why?
|
| Microglia | 1 | 2020 | 1266 | 0.030 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2011 | 25 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 905 | 0.030 |
Why?
|
| Molecular Biology | 3 | 2005 | 596 | 0.030 |
Why?
|
| Immunohistochemistry | 5 | 2004 | 11366 | 0.030 |
Why?
|
| Gelsolin | 2 | 1989 | 190 | 0.030 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 1993 | 142 | 0.030 |
Why?
|
| DNA Repair | 1 | 2021 | 2046 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 829 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2011 | 80 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2004 | 3748 | 0.020 |
Why?
|
| Argininosuccinate Synthase | 1 | 1991 | 15 | 0.020 |
Why?
|
| Adenylate Kinase | 1 | 1991 | 100 | 0.020 |
Why?
|
| Posture | 1 | 2015 | 958 | 0.020 |
Why?
|
| Hippocampus | 2 | 2001 | 3675 | 0.020 |
Why?
|
| Atrophy | 1 | 2016 | 1583 | 0.020 |
Why?
|
| Olfactory Perception | 1 | 2011 | 54 | 0.020 |
Why?
|
| New York | 2 | 2010 | 886 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2011 | 252 | 0.020 |
Why?
|
| Metagenomics | 1 | 2014 | 428 | 0.020 |
Why?
|
| DNA, Satellite | 1 | 1991 | 69 | 0.020 |
Why?
|
| Data Collection | 1 | 2020 | 3341 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2011 | 4011 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 1992 | 354 | 0.020 |
Why?
|
| Logistic Models | 2 | 2019 | 13408 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 851 | 0.020 |
Why?
|
| Electroencephalography | 4 | 2015 | 6150 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2011 | 462 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 895 | 0.020 |
Why?
|
| Blotting, Western | 3 | 2004 | 5179 | 0.020 |
Why?
|
| Serbia | 1 | 2010 | 15 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1420 | 0.020 |
Why?
|
| Hypokinesia | 1 | 2010 | 17 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2012 | 403 | 0.020 |
Why?
|
| Microelectrodes | 1 | 2011 | 303 | 0.020 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1989 | 16 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 1988 | 197 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2000 | 3748 | 0.020 |
Why?
|
| Life Tables | 2 | 2004 | 370 | 0.020 |
Why?
|
| Sex Factors | 3 | 2016 | 10397 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2020 | 25625 | 0.020 |
Why?
|
| Autophagy | 1 | 2018 | 1300 | 0.020 |
Why?
|
| Blotting, Southern | 3 | 2001 | 803 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2010 | 111 | 0.020 |
Why?
|
| Dimerization | 1 | 2011 | 893 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1986 | 570 | 0.020 |
Why?
|
| Genomics | 2 | 2016 | 5720 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 39050 | 0.020 |
Why?
|
| Blotting, Northern | 3 | 2003 | 1581 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2020 | 8436 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2014 | 1850 | 0.020 |
Why?
|
| Glycosylation | 2 | 2004 | 1126 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1708 | 0.020 |
Why?
|
| Acute Disease | 2 | 2010 | 7149 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1989 | 114 | 0.020 |
Why?
|
| Rats | 3 | 2003 | 24260 | 0.020 |
Why?
|
| Incidence | 3 | 2019 | 20947 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 1701 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 1992 | 3508 | 0.020 |
Why?
|
| Angiomatosis | 1 | 1988 | 49 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 901 | 0.020 |
Why?
|
| Valine | 1 | 2010 | 413 | 0.020 |
Why?
|
| Muscle Hypotonia | 1 | 2009 | 165 | 0.020 |
Why?
|
| Korea | 1 | 2007 | 99 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19905 | 0.020 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1988 | 69 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1998 | 4554 | 0.020 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2010 | 231 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 6622 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 1996 | 1471 | 0.020 |
Why?
|
| Ireland | 1 | 2007 | 161 | 0.020 |
Why?
|
| North America | 2 | 2005 | 1249 | 0.020 |
Why?
|
| Receptors, Cell Surface | 2 | 1987 | 2866 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1988 | 323 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 2505 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2011 | 824 | 0.020 |
Why?
|
| Visual Perception | 1 | 2015 | 1420 | 0.020 |
Why?
|
| von Hippel-Lindau Disease | 1 | 1988 | 152 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 279 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2006 | 6314 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1736 | 0.020 |
Why?
|
| Time Factors | 4 | 2016 | 40075 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 2305 | 0.020 |
Why?
|
| Educational Status | 1 | 2014 | 2540 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2006 | 159 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1987 | 351 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2012 | 1354 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 2307 | 0.020 |
Why?
|
| Basal Ganglia | 2 | 1999 | 546 | 0.020 |
Why?
|
| Genome | 1 | 2014 | 1808 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3617 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 2297 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1988 | 313 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2014 | 1809 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2011 | 1420 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2008 | 336 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1986 | 163 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 977 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
| China | 1 | 2011 | 2248 | 0.020 |
Why?
|
| Likelihood Functions | 2 | 2002 | 1005 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 23338 | 0.020 |
Why?
|
| Retinoblastoma | 1 | 1988 | 318 | 0.020 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2004 | 30 | 0.020 |
Why?
|
| Methionine | 1 | 2007 | 590 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2004 | 156 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2886 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2008 | 1032 | 0.020 |
Why?
|
| Epitopes | 1 | 2011 | 2571 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 25043 | 0.020 |
Why?
|
| Databases, Factual | 1 | 1999 | 7729 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2011 | 2716 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2006 | 841 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2010 | 2618 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 3798 | 0.010 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 1456 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 1989 | 817 | 0.010 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2003 | 62 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 402 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 2915 | 0.010 |
Why?
|
| ROC Curve | 1 | 2011 | 3527 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 1987 | 451 | 0.010 |
Why?
|
| Macrophages | 1 | 2018 | 5655 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2004 | 209 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2018 | 63114 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 2002 | 70 | 0.010 |
Why?
|
| Predictive Value of Tests | 3 | 2005 | 15076 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 2645 | 0.010 |
Why?
|
| Neoplasms | 2 | 2010 | 21683 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18029 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 2003 | 165 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1681 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 149 | 0.010 |
Why?
|
| Alzheimer Disease | 2 | 2016 | 8037 | 0.010 |
Why?
|
| Patient Selection | 1 | 2014 | 4215 | 0.010 |
Why?
|
| Consanguinity | 1 | 2004 | 454 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2004 | 1095 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
| Energy Transfer | 1 | 2001 | 109 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2013 | 2899 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10481 | 0.010 |
Why?
|
| Amnesia | 1 | 2003 | 248 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.010 |
Why?
|
| Walking | 1 | 2008 | 1180 | 0.010 |
Why?
|
| Oligonucleotide Probes | 2 | 1991 | 427 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1590 | 0.010 |
Why?
|
| Sweden | 2 | 1995 | 1345 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 2002 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2006 | 881 | 0.010 |
Why?
|
| Fathers | 1 | 2002 | 358 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2004 | 1572 | 0.010 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2000 | 126 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8949 | 0.010 |
Why?
|
| Blepharospasm | 1 | 1999 | 30 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 1999 | 85 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4042 | 0.010 |
Why?
|
| Meige Syndrome | 1 | 1998 | 12 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 3966 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2006 | 1050 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 689 | 0.010 |
Why?
|
| Pregnancy | 2 | 2015 | 29144 | 0.010 |
Why?
|
| Reference Values | 2 | 2001 | 4982 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1998 | 12208 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 1998 | 67 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3846 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 1998 | 141 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 2000 | 410 | 0.010 |
Why?
|
| Dentate Gyrus | 1 | 1999 | 160 | 0.010 |
Why?
|
| Locus Coeruleus | 1 | 1999 | 176 | 0.010 |
Why?
|
| Netherlands | 1 | 2003 | 2170 | 0.010 |
Why?
|
| RNA Probes | 1 | 1998 | 113 | 0.010 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2000 | 198 | 0.010 |
Why?
|
| CpG Islands | 1 | 2002 | 1172 | 0.010 |
Why?
|
| Homovanillic Acid | 1 | 1998 | 75 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 1539 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1998 | 377 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1998 | 286 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 1999 | 224 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1999 | 458 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2011 | 6196 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1998 | 318 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1801 | 0.010 |
Why?
|
| Attention | 1 | 2008 | 2400 | 0.010 |
Why?
|
| Guanine | 1 | 1998 | 274 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12245 | 0.010 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1998 | 163 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 317 | 0.010 |
Why?
|
| Hypoxia, Brain | 1 | 1998 | 133 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6386 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 8324 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2010 | 5985 | 0.010 |
Why?
|
| Handwriting | 1 | 1996 | 28 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2000 | 600 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 1987 | 200 | 0.010 |
Why?
|
| Chromosome Aberrations | 2 | 1996 | 1813 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 1970 | 0.010 |
Why?
|
| History, 17th Century | 1 | 1995 | 111 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1994 | 235 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 15226 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1999 | 587 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1950 | 0.010 |
Why?
|
| Alcohols | 1 | 1994 | 92 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1999 | 792 | 0.010 |
Why?
|
| Flunarizine | 1 | 1992 | 7 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1998 | 1758 | 0.010 |
Why?
|
| United States | 3 | 2011 | 69872 | 0.010 |
Why?
|
| Time | 1 | 1995 | 542 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1996 | 514 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1999 | 1406 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1988 | 3143 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8340 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1992 | 441 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1994 | 468 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6365 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3086 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1991 | 278 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1988 | 4262 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1993 | 367 | 0.010 |
Why?
|
| Polydeoxyribonucleotides | 1 | 1992 | 127 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 8301 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1992 | 1375 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1998 | 12959 | 0.010 |
Why?
|
| Binding Sites | 1 | 1998 | 6114 | 0.010 |
Why?
|
| Fluorescence | 1 | 1992 | 751 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9274 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2002 | 4286 | 0.010 |
Why?
|
| Kidney | 1 | 2004 | 7186 | 0.010 |
Why?
|
| Blood Platelets | 2 | 1989 | 2508 | 0.000 |
Why?
|
| Restriction Mapping | 1 | 1989 | 878 | 0.000 |
Why?
|
| Fetal Diseases | 1 | 1993 | 903 | 0.000 |
Why?
|
| Software | 2 | 1993 | 4443 | 0.000 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1987 | 202 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1987 | 230 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1990 | 1586 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2010 | 53288 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 20129 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1989 | 1124 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1989 | 1726 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1986 | 574 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 7279 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2011 | 77449 | 0.000 |
Why?
|
| Oncogenes | 1 | 1988 | 1265 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1989 | 2126 | 0.000 |
Why?
|
| Melanoma | 1 | 1998 | 5510 | 0.000 |
Why?
|
| Leukocytes | 1 | 1987 | 2043 | 0.000 |
Why?
|
| Skin | 1 | 1989 | 4364 | 0.000 |
Why?
|